Axitinib/Axitinib latest price in 2024

Axitinib/Axitinib is a targeted cancer drug. Axitinib is used alone to treat advanced renal cell carcinoma (RCC) for patients who have failed other drug treatments. Axitinib is used in combination with avelumab (bave ncio) or pembrolizumab (Keytruda) to treat advanced renal cell carcinoma. Axitinib belongs to the kinase inhibitor class of drugs. Axitinib works by blocking the activity of an abnormal protein that sends a reproduction signal to cancer cells, which helps slow or prevent the spread of cancer cells.

Axitinib/Axitinib has been launched in China, and the retail price in domestic pharmacies is about 5mg28 tablets2000 yuan. This drug is available as both original and generic drugs overseas. The retail price of the original drug is about 5mg 28 tablets6000 yuan. Overseas generic drugs are available in Bangladesh, and the retail price of Bikang Pharmaceutical in Bangladesh is about 5mg 60 tablets1800 yuan. Patients can choose drug versions based on their financial situation.

Axitinib/AxitinibThe recommended dosage in the instructions is 5 mg orally, twice daily until the disease develops unacceptable toxicity. Axitinib is a second-generation tyrosine kinase inhibitor that works by selectively inhibiting vascular endothelial growth factor receptors (VEGFR-1, VEGFR-2, VEGFR-3). Through this mechanism of action, axitinib blocks angiogenesis, tumor growth and metastasis. It is reported to be 50-450 times more potent than first-generation VEGFR inhibitors. Axitinib is an indazole derivative that is commonly marketed as Inlyta and is available as an oral formulation. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.